This announcement is a separate document:
麗珠醫藥:於二零二四年十二月二十四日舉行之二零二四年第四次臨時股東大會、二零二四年第二次A股類別股東會及二零二四年第二次H股類別股東會投票表決結果
LIVZON PHARMA: POLL RESULTS OF THE 2024 FOURTH EXTRAORDINARY GENERAL MEETING, THE 2024 SECOND CLASS MEETING OF A SHAREHOLDERS AND THE 2024 SECOND CLASS MEETING OF H SHAREHOLDERS HELD ON 24 DECEMBER 2024
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.